Characteristics (No. of patients) | CD68 hi | CD68 low | P-value |
---|---|---|---|
Gender | |||
Male | 30 | 17 | |
Female | 20 | 14 | 0.647 |
Age(years) | |||
≥ 60 | 20 | 18 | |
< 60 | 30 | 13 | 0.113 |
ECOG PS | |||
0 | 23 | 14 | |
1 | 27 | 17 | 0.941 |
Size of primary tumor (cm) | |||
≥ 5 | 3 | 4 | |
< 5 | 47 | 27 | 0.282 |
Histopathological grading | |||
Low | 24 | 13 | |
Intermediate to high | 26 | 18 | 0.594 |
TNM stage | |||
I + II | 26 | 28 | |
III | 24 | 3 | 0 |
Lymph node invasion | |||
Yes | 14 | 2 | |
No | 36 | 29 | 0.018 |
Microvascular invasion | |||
Yes | 16 | 1 | |
No | 34 | 30 | 0.002 |
HBV | |||
Yes | 18 | 2 | |
No | 32 | 29 | 0.003 |
HCV | |||
Yes | 1 | 1 | |
No | 49 | 30 | 0.73 |
Liver cirrhosis | |||
Yes | 4 | 6 | |
No | 46 | 25 | 0.131 |
Child–Pugh grade | |||
A | 4 | 10 | |
B | 46 | 21 | 0.005 |
CEA (ng/mL) | |||
≥ 10 | 4 | 3 | |
< 10 | 46 | 28 | 0.794 |
CA199(U/mL) | |||
≥ 60 | 36 | 26 | |
< 60 | 14 | 5 | 0.138 |
CA724(U/mL) | |||
≥ 14 | 35 | 20 | |
< 14 | 15 | 11 | 0.607 |
ALT(U/L) | |||
≥ 80 | 37 | 19 | |
< 80 | 13 | 12 | 0.229 |
AST(U/L) | |||
≥ 70 | 30 | 20 | |
< 70 | 20 | 11 | 0.684 |
Total bilirubin (umol/L) | |||
≥ 42 | 44 | 25 | |
< 42 | 6 | 6 | 0.365 |
Direct bilirubin (umol/L) | |||
≥ 16 | 46 | 26 | |
< 16 | 4 | 5 | 0.258 |
Indirect bilirubin (umol/L) | |||
≥ 30 | 33 | 16 | |
< 30 | 17 | 15 | 0.198 |